Chemotherapy-induced peripheral neuropathies in hematological malignancies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-induced peripheral neuropathies in hematological malignancies
Authors
Keywords
Chemotherapy, Neuropathic pain, Hematological, Prevention
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 121, Issue 2, Pages 229-237
Publisher
Springer Nature
Online
2014-10-19
DOI
10.1007/s11060-014-1632-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of older adults with multiple myeloma
- (2013) Antonio Palumbo et al. BLOOD REVIEWS
- Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade
- (2013) G. Trevisan et al. CANCER RESEARCH
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Evidence for Pharmacologic Treatment of Neuropathic Cancer Pain: Beneficial and Adverse Effects
- (2013) Joost L.M. Jongen et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
- (2012) R. Vij et al. BLOOD
- Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
- (2012) H. Zheng et al. EXPERIMENTAL NEUROLOGY
- Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
- (2012) Pieter Sonneveld et al. JOURNAL OF CLINICAL ONCOLOGY
- p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity
- (2012) Carlos F. Ibáñez et al. TRENDS IN NEUROSCIENCES
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
- (2011) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pomalidomide therapy for myeloma
- (2011) Stephen Schey et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
- (2011) S. L. Corthals et al. HAEMATOLOGICA
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Management of treatment-emergent peripheral neuropathy in multiple myeloma
- (2011) P G Richardson et al. LEUKEMIA
- Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
- (2010) S. Bringhen et al. BLOOD
- Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
- (2010) M A Dimopoulos et al. LEUKEMIA
- Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
- (2010) Jewel L. Podratz et al. NEUROBIOLOGY OF DISEASE
- The evidence for pharmacological treatment of neuropathic pain
- (2010) Nanna Brix Finnerup et al. PAIN
- Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
- (2009) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFκB p65
- (2009) Shihui Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
- (2009) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
- Ascorbic acid inhibits antitumor activity of bortezomib in vivo
- (2009) G Perrone et al. LEUKEMIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now